DataVXAdvanced MaterialsPaper
journal article·2016-12Open access

Gold Nanorods, DNA Origami, and Porous Silicon Nanoparticle‐functionalized Biocompatible Double Emulsion for Versatile Targeted Therapeutics and Antibody Combination Therapy

Feng Kong, Hongbo Zhang, Xiangmeng Qu, Xu Zhang, Dong Chen, Ruihua Ding, Ermei Mäkilä, Jarno Salonen, Hélder A. Santos, Mingtan Hai

Advanced Materials· Volume 28· Issue 46
Publisher pageOpen full text
Source abstract

Abstract

Gold nanorods, DNA origami, and porous silicon nanoparticle-functionalized biocompatible double emulsion are developed for versatile molecular targeted therapeutics and antibody combination therapy. This advanced photothermal responsive all-in-one biocompatible platform can be easily formed with great therapeutics loading capacity for different cancer treatments with synergism and multidrug resistance inhibition, which has great potential in advancing biomedical applications. As a service to our authors and readers, this journal provides supporting information supplied by the authors. Such materials are peer reviewed and may be re-organized for online delivery, but are not copy-edited or typeset. Technical support issues arising from supporting information (other than missing files) should be addressed to the authors. Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.
Source: openalex_inverted_index · Quality: baseline

Research context

NanomaterialsBiomaterials

OpenAlex topics: Advanced biosensing and bioanalysis techniques · Nanoparticle-Based Drug Delivery · RNA Interference and Gene Delivery

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Beijing Key Laboratory of Function Materials for Molecule and Structure Construction School of Materials Science and Engineering University of Science and Technology Beijing Beijing 100083 P. R. China

Harvard John A. Paulson School of Engineering and Applied Sciences Harvard University Cambridge MA 02138 USA

Division of Pharmaceutical Chemistry and Technology Faculty of Pharmacy University of Helsinki Helsinki FI‐00014 Finland

School of Chemistry and Molecular Engineering East China Normal University 500 Dongchuan Road Shanghai 200241 P. R. China

Cape Breton University 1250 Grand Lake Road Sydney NS B1P 6L2 Canada

Laboratory of Industrial Physics Department of Physics University of Turku FI‐20014 Turku Finland

Funding

National Science Foundation · Jane ja Aatos Erkon Säätiö · China Scholarship Council · Suomen Akatemia · European Research Council

References (47)

Show source-provided references
1. 10.4155/tde.10.1310.4155/tde.10.13 ↗
2. 10.1038/nbt.154910.1038/nbt.1549 ↗
3. 10.1126/science.109583310.1126/science.1095833 ↗
4. 10.1002/adfm.20080127110.1002/adfm.200801271 ↗
5. 10.1016/j.jconrel.2009.09.02310.1016/j.jconrel.2009.09.023 ↗
6. 10.1002/adfm.20150059410.1002/adfm.201500594 ↗
7. 10.3109/0265204090313130110.3109/02652040903131301 ↗
8. 10.1016/S0939-6411(96)00037-910.1016/S0939-6411(96)00037-9 ↗
9. 10.1023/A:102269351640910.1023/A:1022693516409 ↗
10. 10.1021/la048033610.1021/la0480336 ↗
11. 10.1016/j.actbio.2014.11.01910.1016/j.actbio.2014.11.019 ↗
12. 10.1016/j.biomaterials.2014.07.05010.1016/j.biomaterials.2014.07.050 ↗
13. 10.2217/nnm.13.22310.2217/nnm.13.223 ↗
14. 10.1016/j.biomaterials.2013.06.05210.1016/j.biomaterials.2013.06.052 ↗
15. 10.1039/b715524g10.1039/b715524g ↗
16. 10.1002/smll.20130374010.1002/smll.201303740 ↗
17. 10.1021/ja063568210.1021/ja0635682 ↗
18. 10.1021/am403999q10.1021/am403999q ↗
19. 10.1002/adfm.20140412210.1002/adfm.201404122 ↗
20. 10.1016/j.biomaterials.2014.10.07910.1016/j.biomaterials.2014.10.079 ↗
21. 10.1002/adma.20140095310.1002/adma.201400953 ↗
22. 10.1002/adma.20140540810.1002/adma.201405408 ↗
23. 10.1021/la404201m10.1021/la404201m ↗
24. 10.2174/15701631179679905310.2174/157016311796799053 ↗
25. 10.1016/j.jconrel.2013.05.03610.1016/j.jconrel.2013.05.036 ↗
26. 10.1002/adfm.20120249110.1002/adfm.201202491 ↗
27. 10.1021/ja200729w10.1021/ja200729w ↗
28. 10.2174/15672010677855905610.2174/156720106778559056 ↗
29. 10.1038/nrd219710.1038/nrd2197 ↗
30. 10.1016/S0169-409X(96)00494-210.1016/S0169-409X(96)00494-2 ↗
31. 10.2174/09298670777931337210.2174/092986707779313372 ↗
32. 10.1021/nn301389c10.1021/nn301389c ↗
33. 10.1021/ja109936h10.1021/ja109936h ↗
34. 10.1002/adma.20080278910.1002/adma.200802789 ↗
35. 10.1002/adfm.20160271510.1002/adfm.201602715 ↗
36. 10.1038/2899810.1038/28998 ↗
37. 10.1038/nature0458610.1038/nature04586 ↗
38. 10.1021/nn502058j10.1021/nn502058j ↗
39. 10.1021/ja304263n10.1021/ja304263n ↗
40. 10.1038/nrc169110.1038/nrc1691 ↗
41. 10.1021/nn203161y10.1021/nn203161y ↗
42. 10.1021/nn200693a10.1021/nn200693a ↗
43. Greco W. R. · Pharmacol. Rev. · 1995 · 47 · 33110.1016/S0031-6997(25)06847-4 ↗
44. 10.1016/S0928-0987(02)00055-610.1016/S0928-0987(02)00055-6 ↗
45. 10.1016/S0378-5173(02)00347-210.1016/S0378-5173(02)00347-2 ↗
46. 10.1158/1078-0432.CCR-07-508810.1158/1078-0432.CCR-07-5088 ↗
47. 10.1002/smll.20150211810.1002/smll.201502118 ↗